ESMO Media Releases

The award will be presented at the European Lung Cancer Conference (ELCC) 2015, held 15 to 18 April in Geneva, Switzerland

A course dedicated to educating the next generation of oncologists about the essentials of clinical trial design, implementation, and analysis, will be organised this week by ESMO

On World Cancer Day 2015, ESMO acknowledges patient’s right to access treatment and highlights collaborative efforts towards improving access for all

New website section dedicated to research funding opportunities created to promote and improve clinical cancer research in Europe

High-dose interleukin-2 can be effective in selected metastatic renal cell cancer patients pre-treated with VEGF-targeted agents, reveals research presented today at the ESMO Symposium on Immuno-Oncology in Geneva, Switzerland.

New evidence that immune checkpoint inhibitors may work in glioblastoma and brain metastases was presented today by Dr Anna Sophie Berghoff at the ESMO Symposium on Immuno-Oncology 2014 in Geneva, Switzerland

The possibilities for personalised vaccines in all types of cancer are revealed today in a lecture from Dr Harpreet Singh at the ESMO Symposium on Immuno-Oncology 2014 in Geneva, Switzerland

Immunotherapy is set to revolutionise the treatment of cancer, according to ESMO President Professor Rolf A. Stahel. His comments come as the ESMO Symposium on Immuno-Oncology 2014 is about to open in Geneva, Switzerland tomorrow. 

ESMO announced today that it will be organising an annual Congress in Europe starting in 2016

A record number of 19,859 attendees at the ESMO 2014 Congress discussed changes to oncology that will soon have a positive impact on the care of patients around the world.

Corrigendum: Please note the updated data for the response rate is 52% instead of 43%